Provider review
FitFlow review
Puts the flat-dose promise on every product card, not in a banner.
The same GLP-1 figure appears as a rate on the card and as a floor in the hero.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
FitFlow
$99/mo semaglutide and $134/mo tirzepatide, flat at every dose
- Vs median
- $70/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Putting the flat-dose promise on each product card rather than in a banner is a small choice that does real work. Comparing the tirzepatide card against the semaglutide card, you see the promise twice, attached to the thing you are actually buying, rather than once above a page you may have scrolled straight past. The wording is explicit about what it means — your cost never goes up as your dosage changes — which is the version a seller can be held to rather than the vague one. Two inconsistencies are worth knowing before comparing. The GLP-1 figures appear as plain rates on the cards and as a from price in the hero, so one number is doing two different jobs on one site. And the two peptide lines are quoted as floors while the two GLP-1 lines are not, which means the catalog is not priced on a single basis even though it looks like it is. No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the flat-dose promise attached to the product rather than the page
- You want the promise spelled out rather than implied by a phrase
- You want peptides available from the same provider
Look elsewhere if
- You are comparing precisely — the same figure is a rate in one place and a floor in another
- You want the whole catalog priced on one basis
- You want a dose behind the number
What it actually costs
Price as published
★ THE FLAT-DOSE PROMISE IS ATTACHED TO EACH PRODUCT, not to the page: "Same price at every dose" appears under compounded tirzepatide at $134/month and again under compounded semaglutide at $99/month, with the explanation stated once in full — "your cost never goes up as your dosage changes" · so the promise travels with the product a reader is actually looking at rather than sitting in a banner above everything · sermorelin is listed "from $175/mo" and NAD+ "from $165/mo", both introduced by "from" while the two GLP-1 figures are not · the hero uses "from $99/month" for the GLP-1 line, so the same figure appears once as a rate and once as a floor on the same site · free expedited shipping and FSA/HSA eligibility are stated · no milligram is published
- Vs median
- $70/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. ★ The flat-dose promise is attached to each product card rather than to the page, and its meaning is spelled out: the cost does not rise as the dose changes. That is the version a seller can be held to. The catalog is not priced on one basis though — the GLP-1 lines appear as plain rates on the cards and as a floor in the hero, while the peptide lines are floors throughout. No dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- The flat-dose promise sits on each product card rather than in a banner above the page.
- States plainly what the promise means: cost does not rise as the dose changes.
- Free expedited shipping and FSA/HSA eligibility are stated up front.
Pharmacy, labs and oversight
FitFlow does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What FitFlow publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Putting the flat-dose promise on each product card rather than in a banner is a small choice that does real work: a reader comparing the tirzepatide card against the semaglutide card sees the promise twice, attached to the thing being bought, rather than once above a page they may have scrolled past. The wording is explicit about what it means — the cost does not go up as the dose changes — which is the version that can actually be held to. Two inconsistencies are worth knowing. The GLP-1 figures appear as plain rates on the cards and as a from price in the hero, so the same number is doing two jobs on one site. And the two peptide lines are quoted as floors while the two GLP-1 lines are not, which means the catalog is not priced on a single basis even though it looks like it is. No milligram appears against any figure.
The honest cons
The same GLP-1 figure appears as a rate on the card and as a floor in the hero.
- The peptide lines are quoted as floors while the GLP-1 lines are not.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
FitFlow is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#330 of 373
Ordered with the companies that pay us first, and FitFlow is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.